Biosig Technologies (NASDAQ:STEX), operating as Streamex Corp, said its first quarter of 2026 marked a transition from product preparation to early commercialization, highlighted by the launch of its tokenized gold product, the payment of initial dividends to holders and the retirement of its convertible debt.
Executive Chairman Morgan Lekstrom told investors that Streamex is positioning itself as a full infrastructure provider and issuer for tokenized real-world assets, including commodities and securities. He described the company’s business model as fee-driven, capital-light and focused on tokenization fees, technology use fees and management fees as assets under management grow.